๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

18 recruiting trials

for Malaria,Falciparum

Mass Vaccine and Drug Administration, Bangladesh NCT06068530Phase 42 sites๐Ÿ“ Bฤndarban๐Ÿ“ Lฤma University of Oxford ยท Tests: DHA/piperaquine and a SLD-PQ, Study vaccine R21/Matrix-Mโ„ข Platelet-Directed Whole Blood Transfusion Strategy for Malaria NCT05711485NA2 sites๐Ÿ“ Baltimore๐Ÿ“ Ndola Johns Hopkins Bloomberg School of Public Health ยท Tests: Whole blood transfusion A Study to Find Out if a Combination of 3 Medicines for the Treatment of Malaria Works as Well and is as Safe and Tolerable as Combinations of 2 Medicines NCT05951595Phase 31 site๐Ÿ“ Ruhuha University of Oxford ยท Tests: Artemether-Lumefantrine-Amodiaquine (ALAQ), Artemether-Lumefantrine (AL), Artesunate-Amodiaquine (ASAQ) Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar NCT06923592Phase 32 sites๐Ÿ“ Addis Ababa๐Ÿ“ Antananarivo London School of Hygiene and Tropical Medicine ยท Tests: PvSeroTAT, Control Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort C2) NCT07811908Phase 213 sites๐Ÿ“ Banfora๐Ÿ“ Nanoro๐Ÿ“ Abidjan Novartis Pharmaceuticals ยท Tests: KAE609, SoC (Coartem), KLU156 Assessing Vaccine Effectiveness of R21/Matrix-M Across Malaria Transmission Settings (AVERT) NCT07749911n/a21 sites๐Ÿ“ Boromo๐Ÿ“ Boromo๐Ÿ“ Houndรฉ Clinton Health Access Initiative Inc. ยท Tests: R21/Matris-M Malaria vaccine A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 Months NCT07036159Phase 22 sites๐Ÿ“ Kigali๐Ÿ“ Kigali GlaxoSmithKline ยท Tests: RTS,S/AS01E vaccine An Observational Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria Vaccine NCT07009847n/a5 sites๐Ÿ“ Bousse๐Ÿ“ Toumodi๐Ÿ“ Yenagoa Serum Institute of India Pvt. Ltd. ยท Tests: Case control study of clinical malaria, Case control study of severe malaria, Case control study of death (all cause) Safety and Efficacy of Imatinib in Combination With Artemether-Lumefantrine for Uncomplicated Malaria NCT07559370Phase 21 site๐Ÿ“ Kisumu Victoria Biomedical Research Institute ยท Tests: Artemether lumefantrine tablets, Artemether Lumefantrine and Imatinib Mesylate Assessing the Feasibility of Combining Dihydroartemisinin Piperaquine and Primaquine for Malaria Mass Drug Administration in High Endemic Communities in the Eastern Region of Ghana NCT07389057NA1 site๐Ÿ“ Accra Noguchi Memorial Institute for Medical Research ยท Tests: DHAP, Single low dose PQ DON in Pediatric Cerebral Malaria NCT05478720Phase 1, Phase 22 sites๐Ÿ“ Blantyre๐Ÿ“ Blantyre Douglas Postels, MD, MS ยท Tests: 6-diazo-5-oxo-L-norleucine (DON), Placebo, 6-diazo-5-oxo-L-norleucine (DON) Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine Candidates NCT02471378n/a1 site๐Ÿ“ Bamako National Institute of Allergy and Infectious Diseases (NIAIโ€ฆ Field Trial of PfSPZ-LARC2 Vaccine in Burkinabe Adults NCT07385287Phase 21 site๐Ÿ“ Ouagadougou Sanaria Inc. ยท Tests: Genetically attenuated PfSPZ Vaccine, Normal Saline (0.9% Sodium Chloride) Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of LAI MMV055 Alone and in Combination With MMV371 in Healthy Participants NCT07011511Phase 11 site๐Ÿ“ Nottingham Medicines for Malaria Venture ยท Tests: MMV055 Dose 1, MMV055 Dose 2, MMV055 Dose 3, MMV055 Dose 4, MMV055 Dose 5 Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria NCT05750628Phase 212 sites๐Ÿ“ Banfora๐Ÿ“ Nanoro๐Ÿ“ Abidjan Novartis Pharmaceuticals ยท Tests: INE963, KAE609 (Cipargamin), SoC (Coartem), KLU156 First-in-Human Dose-escalation of GSK4425689A: Safety, Tolerability, and PK in Healthy Adults NCT07646353Phase 11 site๐Ÿ“ Manchester GlaxoSmithKline ยท Tests: GSK4425689A SC, GSK4425689A IV, Placebo Safety, Tolerability and Efficacy of PfSPZ-LARC2 Vaccine Against CHMI in Malaria-Naรฏve Adults NCT06862453Phase 11 site๐Ÿ“ Tรผbingen Sanaria Inc. ยท Tests: Normal Saline (Placebo), PfSPZ-LARC2 Vaccine, PfSPZ Challenge (NF54) PfSPZ-LARC2 Vaccine in Women of Child-bearing Potential (WOCBP) in Mali NCT07675785Phase 21 site๐Ÿ“ Bamako Sanaria Inc. ยท Tests: PfSPZ-LARC2 Vaccine, Normal Saline
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy